The Ergomed team is looking forward to exhibiting at the World Orphan Drug Congress USA taking place in Boston, MA, between 11-13 July.
The World Orphan Drug Congress USA brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
Our Ergomed Rare Disease team will be exhibiting for three days in Boston for the most comprehensive program and inclusive gathering of rare disease stakeholders. We encourage you to listen to our rare disease expert, Zizi Imatorbhebhe on Leveraging technology platforms: Evolving the IND/regulatory process and funding models to meet the needs of more patients as a panel speaker.
We invite you to visit our booth, #528 to meet our expert and commercial team.
Zizi Imatorbhebhe I MBA, MS, PMP®
Senior Vice President, Global Strategy and Development,
Head Rare Disease Innovation Center
Danko Dominis, MD, PhD
SVP Business Development & Strategic Accounts
Senior Director, Business Development